Cargando…

Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database

BACKGROUND: Active surveillance after orchiectomy is the preferred management in clinical stage I (CSI) germ-cell tumours (GCT) associated with a 15 to 30% relapse rate. PATIENTS AND METHODS: In the IGCCCG Update database, we compared the outcomes of gonadal disseminated GCT relapsing from initial C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lauritsen, Jakob, Sauvé, Nicolas, Tryakin, Alexey, Jiang, Di Maria, Huddart, Robert, Heng, Daniel Y. C., Terbuch, Angelika, Winquist, Eric, Chovanec, Michal, Hentrich, Marcus, Fankhauser, Christian D., Shamash, Jonathan, del Muro, Xavier Garcia, Vaughn, David, Heidenreich, Axel, Sternberg, Cora N., Sweeney, Christopher, Necchi, Andrea, Bokemeyer, Carsten, Bandak, Mikkel, Jandari, Abolghassem, Collette, Laurence, Gillessen, Silke, Beyer, Joerg, Daugaard, Gedske
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667594/ https://www.ncbi.nlm.nih.gov/pubmed/37777577 http://dx.doi.org/10.1038/s41416-023-02443-3

Ejemplares similares

Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
por: Gillessen, Silke, et al.
Publicado: (2021)

Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
por: Beyer, Jörg, et al.
Publicado: (2021)

Prechemotherapy Not Preorchiectomy Serum Tumor Markers Accurately Identify International Germ Cell Cancer Collaborative Group Prognostic Groups in Nonseminoma
por: Fankhauser, Christian D., et al.
Publicado: (2023)

Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment
por: Majewski, Matthäus, et al.
Publicado: (2023)

A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)
por: Bandak, Mikkel, et al.
Publicado: (2017)

Prediction of Nephrotoxicity Associated With Cisplatin-Based Chemotherapy in Testicular Cancer Patients
por: Garcia, Sara L, et al.
Publicado: (2020)

Predicting Hearing Loss in Testicular Cancer Patients after Cisplatin-Based Chemotherapy
por: Garcia, Sara L., et al.
Publicado: (2023)

Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE)
por: Kreiberg, Michael, et al.
Publicado: (2018)

Neurological Adverse Effects after Radiation Therapy for Stage II Seminoma
por: Ebbeskov Lauritsen, Liv, et al.
Publicado: (2012)

The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3)
por: Seidel, Christoph, et al.
Publicado: (2021)

IGCCCG-Fehlklassifikation (International Germ Cell Consensus Classification) durch zeitlich inkorrekte Interpretation der Serumkonzentration der Tumormarker bei metastasierten testikulären Keimzelltumoren
por: Paffenholz, Pia, et al.
Publicado: (2021)

Peritoneal carcinosis in male germ cell tumor patients: a registry study compiled by the German Testicular Cancer Study Group (GTCSG)
por: Seidel, Christoph, et al.
Publicado: (2022)

Prognostic factors for relapse in patients with clinical stage I testicular cancer: protocol for a Danish nationwide cohort study
por: Wagner, Thomas, et al.
Publicado: (2019)

The Danish Testicular Cancer database
por: Daugaard, Gedske, et al.
Publicado: (2016)

At what price do we treat patients with testicular cancer?
por: Daugaard, Gedske
Publicado: (2013)

A Validated Algorithm for Register-Based Identification of Patients with Relapse of Clinical Stage I Testicular Cancer
por: Wagner, Thomas, et al.
Publicado: (2023)

Optimized detection of germ cell neoplasia in situ in contralateral biopsy reduces the risk of second testis cancer
por: Rajpert‐De Meyts, Ewa, et al.
Publicado: (2022)

Danish translation and pilot testing of the European Organization for Research and Treatment of Cancer QLQ-TC 26 (EORTC QLQ-TC26) questionnaire to assess health-related quality of life in patients with testicular cancer
por: Bager, Louise, et al.
Publicado: (2018)

Diagnostic Dilemma: Lymphocytopenia in a Patient with Thymoma – Side Effect due to Irradiation Treatment or Development of Good's Syndrome?
por: Raaschou-Jensen, Klas, et al.
Publicado: (2010)

Evaluation of Circulating miRNA Biomarkers of Testicular Germ Cell Tumors during Therapy and Follow-up―A Copenhagen Experience
por: Mørup, Nina, et al.
Publicado: (2020)

Perfluorooctanoic Acid (PFOA) Exposures and Incident Cancers among Adults Living Near a Chemical Plant
por: Barry, Vaughn, et al.
Publicado: (2013)

Febrile Neutropenia and Long-term Risk of Infection Among Patients Treated With Chemotherapy for Malignant Diseases
por: Nordvig, Josefine, et al.
Publicado: (2018)

Oncological Follow-up Strategies for Testicular Germ Cell Tumours: A Narrative Review
por: Kaufmann, Ernest, et al.
Publicado: (2022)

Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance
por: Chung, Peter, et al.
Publicado: (2015)

Prediction of Febrile Neutropenia after Chemotherapy Based on Pretreatment Risk Factors among Cancer Patients
por: Aagaard, Theis, et al.
Publicado: (2017)

Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604)
por: Cafferty, Fay H., et al.
Publicado: (2020)

Mortality and Risk of Cancer After Prophylactic Bilateral Oophorectomy in Women With a Family History of Cancer
por: Abildgaard, Julie, et al.
Publicado: (2018)

1549. Development and Validation of a Cycle-Specific Risk Score for Febrile Neutropenia After Chemotherapy in Patients with Cancer: The (CSR)FENCE Score
por: Aagaard, Theis, et al.
Publicado: (2018)

The Value of Tumour Markers in the Detection of Relapse—Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study
por: Fischer, Stefanie, et al.
Publicado: (2023)

2613. The Epidemiology of Respiratory Syncytial Virus (RSV) in People with Immune Dysfunction Seen at a Tertiary Hospital Between 2010 and 2017
por: Li, Qiuju, et al.
Publicado: (2019)

Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first‐line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3)
por: Tran, Ben, et al.
Publicado: (2019)

Progressive Resistance Training and Cancer Testis (PROTRACT) - Efficacy of resistance training on muscle function, morphology and inflammatory profile in testicular cancer patients undergoing chemotherapy: design of a randomized controlled trial
por: Christensen, Jesper F, et al.
Publicado: (2011)

Mortality and admission to intensive care units after febrile neutropenia in patients with cancer
por: Aagaard, Theis, et al.
Publicado: (2020)

Next Generation Cancer Vaccines—Make It Personal!
por: Terbuch, Angelika, et al.
Publicado: (2018)

A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)
por: Huddart, Robert A., et al.
Publicado: (2015)

Development and Validation of a Risk Score for Febrile Neutropenia After Chemotherapy in Patients With Cancer: The FENCE Score
por: Aagaard, Theis, et al.
Publicado: (2018)

Luteinizing Hormone Receptor Is Expressed in Testicular Germ Cell Tumors: Possible Implications for Tumor Growth and Prognosis
por: Lorenzen, Mette, et al.
Publicado: (2020)

Small RNAs in Seminal Plasma as Novel Biomarkers for Germ Cell Tumors
por: Mørup, Nina, et al.
Publicado: (2021)

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2019)

Association between polymorphisms in the aryl hydrocarbon receptor repressor gene and disseminated testicular germ cell cancer
por: Brokken, Leon J. S., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g1hp2hnubo1ulrv8rgqgvaocdq